The binding of the anti-heparin platelet factor 4 (PF4) released by the α granules of the platelets to the NETs contributes to make the latter resistant to DNase and this explains the high levels of PF4 and NET in COVID-19 patients (Gollomp et al., 2018[22]). This evidence concerns the gene PF4 and COVID-19.